Hope for a cure and altruism are the main motives behind participation in phase 3 clinical cancer trials. [electronic resource]
Producer: 20161026Description: 133-41 p. digitalISSN:- 1365-2354
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.